Suppression of Zinc Finger Homeobox 3 expression in tumor cells decreases the survival rate among non-small cell lung cancer patients

Cancer Biomarkers

Volumn 11, Issue 4, 2012, Pages 139-146

  Minamiya, Yoshihiro ^a   Saito, Hajime ^a   Ito, Manabu ^a   Imai, Kazuhiro ^a   Konno, Hayato ^a   Takahashi, Naoko ^a   Motoyama, Satoru ^a   Ogawa, Jun Ichi ^a  

^a AKITA UNIVERSITY HOSPITAL   (Japan)

Author keywords

alpha fetoprotein; AT motif binding factor 1; non small cell lung cancer; Prognosis; RT PCR; Zinc Finger Homeobox 3

Indexed keywords

MESSENGER RNA; PLATINUM DERIVATIVE; TEGAFUR; UNCLASSIFIED DRUG; URACIL; ZINC FINGER HOMEOBOX 3 PROTEIN; ZINC FINGER PROTEIN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; ZINC FINGERS;

EID: 84871567856     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2012-00272     Document Type: Article

References (28)

1. Shen F, Kirmani KZ, Xiao Z, Thirlby BH, Hickey RJ, Malkas LH. (2011) Nuclear protein isoforms: Implications for cancer diagnosis and therapy. J Cell Biochem. 112:756-60.
2. Skoudy A, Herńandez-Munoz I, Navarro P. (2011) Pancreatic ductal adenocarcinoma and transcription factors: role of c-Myc. J Gastrointest Cancer. 42:76-84.
3. Morinaga T, Yasuda H, Hashimoto T, Higashio K, Tamaoki T. (1991) A human alpha-fetoprotein enhancer-binding protein, ATBF1, contains four homeodomains and seventeen zinc fingers. Mol Cell Biol. 11:6041-9. (Pubitemid 21895375)
4. Yamada K, Miura Y, Scheidl T, Yoshida MC, Tamaoki T. (1995) Assignment of the human ATBF1 transcription factor gene to chromosome 16q22.3-q23.1. Genomics. 29:552-3.
5. Sun X, Zhou Y, Otto KB, Wang M, Chen C, Zhou W, Subramanian K, Vertino PM, Dong JT. (2007) Infrequent mutation of ATBF1 in human breast cancer. J Cancer Res Clin Oncol. 133:103-5. (Pubitemid 44950242)
6. Sun X, Frierson HF, Chen C, Li C, Ran Q, Otto KB, Cantarel BL, VessellaRL, GaoAC, Petros J,MiuraY,Simons JW, Dong JT. (2005) Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer. Nat Genet. 37:407-12.
7. KaiK, Zhang Z,YamashitaH,YamamotoY,MiuraY, IwaseH. (2008) Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancer. BMC Cancer. 8:262.
8. Cho YG, Song JH, Kim CJ, Lee YS, Kim SY, Nam SW, Lee JY, ParkWS. (2007) Genetic alterations of the ATBF1 gene in gastric cancer. Clin Cancer Res. 13:4355-9.
9. Dong XY, Sun X, Guo P, Li Q, Sasahara M, Ishii Y, Dong JT. (2010) ATBF1 inhibits estrogen receptor (ER) function by selectively competing with AIB1 for binding to the ER in ER-positive breast cancer cells. J Biol Chem. 285:32801-9.
10. Zhang Z, Yamashita H, Toyama T, Sugiura H, Ando Y, Mita K, Hamaguchi M, Kawaguchi M, Miura Y, Iwase H. (2005) ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancer. Clin Cancer Res. 11:193-8. (Pubitemid 40075795)
11. Kataoka H, Miura Y, Joh T, Seno K, Tada T, Tamaoki T, Nakabayashi H,Kawaguchi M, Asai K, Kato T, Itoh M. (2001) Alpha-fetoprotein producing gastric cancer lacks transcription factor ATBF1. Oncogene. 20:869-73. (Pubitemid 32198180)
12. Kim CJ, Song JH, Cho YG, Cao Z, Lee YS, Nam SW, Lee JY, Park WS. (2008) Down-regulation of ATBF1 is a major inactivating mechanism in hepatocellular carcinoma. Histopathology. 52:552-9. (Pubitemid 351442655)
13. Goldstraw P. (2009) The 7th Edition of TNMin Lung Cancer: What Now? J Thorac Oncol. 4:671-3.
14. Maddau C, Confortini M, Bisanzi S, Janni A, Montinaro F, Paci E, Pontenani G, Rulli P, Salani A, Zappa M, Benvenuti A, Carozzi FM. (2006) Prognostic significance of p53 and Ki-67 antigen expression in surgically treated non-small cell lung cancer: immunocytochemical detectionwith imprint cytology. Am J Clin Pathol. 125:425-31. (Pubitemid 43327713)
15. Rosell R, Skrzypski M, Jassem E, Taron M, Bartolucci R, Sanchez JJ, Mendez P, Chaib I, Perez-Roca L, Szymanowska A, RzymanW, Puma F, Kobierska-Gulida G, Farabi R, Jassem J. (2007) BRCA1: A novel prognostic factor in resected nonsmall-cell lung cancer. PLoS One. 7:e1129.
16. Kubokura H, Tenjin T, Akiyama H, Koizumi K, Nishimura H, Yamamoto M, Tanaka S. (2001) Relations of the c-myc gene and chromosome 8 in non-small cell lung cancer: analysis by fluorescence in situ hybridization. Ann Thorac Cardiovasc Surg. 7:197-203.
17. Vousden KH, LuX (2002). "Live or let die: the cell's response to p53". Nat Rev Cancer 2:594-604. (Pubitemid 37328926)
18. HaberDA, BucklerAJ (1992).WT1: a novel tumor suppressor gene inactivated in Wilms' tumor. New Biol 4: 97-106.
19. Venkitaraman AR (2002). Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108: 171-182. (Pubitemid 34161138)
20. Miyaki M, Kuroki T (2003). Role of Smad4 (DPC4) inactivation in human cancer. Biochem Biophys Res Commun 306: 799-804. (Pubitemid 36776201)
21. Seth A, Watson DK. 2005 ETS transcription factors and their emerging roles in human cancer. Eur J Cancer. 41:2462-78. (Pubitemid 41540623)
22. Bollrath J, Greten FR. IKK/NF-kappaB and STAT3 pathways: Central signalling hubs in inflammation-mediated tumour promotion and metastasis. 2009 EMBO Rep. 10:1314-9.
23. Taniguchi Y, Choi PJ, Li GW, Chen H, Babu M, Hearn J, Emili A, Xie XS. (2010) Quantifying E. coli proteome and transcriptome with single-molecule sensitivity in single cells. Science.329:533-8.
24. Yasuda H, Mizuno A, Tamaoki T, Morinaga T. (1994) ATBF1, a multiple-homeodomain zinc finger protein, selectively down-regulates AT-rich elements of the human alphafetoprotein gene. Mol Cell Biol. 14:1395-401.
25. MabuchiM, Kataoka H, Miura Y, Kim TS, Kawaguchi M, Ebi M, Tanaka M, Mori Y, Kubota E, Mizushima T, Shimura T, Mizoshita T, Tanida S, Kamiya T, Asai K, Joh T. (2010) Tumor suppressor, ATmotif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response toTGF-beta signal transduction.BiochemBiophys Res Commun. 398:321-5.
26. Miura Y, Kataoka H, Joh T, Tada T, Asai K, Nakanishi M, Okada N, Okada H. (2004) Susceptibility to killer T cells of gastric cancer cells enhanced byMitomycin-C involves induction of ATBF1 and activation of p21 (Waf1/Cip1) promoter. Microbiol Immunol. 48:137-45. (Pubitemid 38248341)
27. Mori Y, Kataoka H, Miura Y, Kawaguchi M, Kubota E, Ogasawara N, Oshima T, Tanida S, Sasaki M, Ohara H, Mizoshita T, TatematsuM, Asai K, Joh T. (2007) Subcellular localization of ATBF1 regulates MUC5AC transcription in gastric cancer. Int J Cancer. 121:241-7. (Pubitemid 46917691)
28. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, Franklin W, Gazdar A, Gould M, Hasleton P, Henderson D, Johnson B, Johnson D, Kerr K, Kuriyama K, Lee JS, Miller VA, Petersen I, Roggli V, Rosell R, Saijo N, Thunnissen E, Tsao M, Yankelewitz D. (2011) International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J ThoracOncol. 6:244-85.